In Belarus adjusted the regulation of prices for medicines

The Ministry of Health clarified some issues of regulation of prices for medicines. This is stipulated by the Ministry’s Resolution No. 102 dated September 17, 2026, which is published on the National Legal Internet Portal.

Amendments were made to the resolution of the department of March 6, 2012 No. 13. One of the paragraphs of the Instruction on the procedure for establishing and applying regulated prices for medicines has been adjusted.

It is determined that the organizations set selling prices independently, but not above the maximum selling prices established by the Resolution of the Ministry of Health of September 17, 2026 No. 101 "On the establishment of maximum selling prices for medicines produced by organizations of the Republic of Belarus".

Recognized invalid by the decree of the Ministry of Health of October 24, 2025 No. 165 and of February 9, 2026 No. 8.

The decree comes into force on October 1, 2026.

As previously reported, Resolution No. 101 determined maximum selling prices for drugs for various purposes: antiparasitic, dermatological, anti-infectious, antitumor and immunomodulatory agents, drugs for the respiratory system, digestive tract and metabolism, blood and blood-forming organs, nervous system, for the treatment of diseases of the senses.

The list of medicines of such manufacturers as "Belmedpreparaty", "Pharmland", "Belaseptic", "Reb-pharma", "Pharmtechnologiya", Borisov Medical Products Plant, Nesvizh Medical Products Plant, "Academfarm", Bobruisk Biotechnology Plant and "Ferain".

The document also establishes maximum selling prices for gaseous and liquid oxygen. It is fixed that the price of gaseous oxygen includes the cost of works, services for filling the balloon, loading and unloading works on the territory of the legal entity engaged in the production of gaseous oxygen, temporary use by the consumer of the balloon.